| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.25 | 2e-11 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-10 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.21 | 8e-09 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.23 | 8e-09 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.31 | 6e-08 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.19 | 8e-07 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-06 |
| mRNA | BMS-536924 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-06 |